Bainbridge Health Welcomes B. Braun to the National Infusion Collaborative™

June 11, 2025 02:27 AM AEST | By EIN Presswire
 Bainbridge Health Welcomes B. Braun to the National Infusion Collaborative™
Image source: EIN Presswire

Bainbridge Health announced that B. Braun Medical Inc. (B. Braun) has joined the National Infusion Collaborative (NIC). PHILADELPHIA, PA, UNITED STATES, June 10, 2025 /EINPresswire.com/ -- Bainbridge Health, a leading provider of medication safety and stewardship solutions, today announced that B. Braun Medical Inc. (B. Braun), a global medical technology leader, has joined the National Infusion Collaborative (NIC). As a leading infusion pump and solutions manufacturer, B. Braun's participation will enhance the NIC's mission to cultivate intra-industry collaboration and education.

Bainbridge Health, in partnership with Purdue University’s Regenstrief Center for Healthcare Engineering, a collaborative research leader working to improve the quality, accessibility, and affordability of healthcare delivery, launched the NIC in 2022 with a mission to improve the safety and stewardship of medication use. Since then, the NIC has grown to become the leading national network of infusion practitioners in the United States, championing national benchmarking and clinical education.

B. Braun is recognized globally for its extensive portfolio of medical products and infusion therapy solutions designed to improve patient care and clinical outcomes. With its commitment to innovation, particularly in smart infusion systems and interoperability, B. Braun brings valuable expertise and practical insights to the NIC.

"We are excited to welcome B. Braun to the National Infusion Collaborative," said Sean O'Neill, Pharm.D., Co-Chair of the NIC and Chief Clinical Officer of Bainbridge Health. "Their dedication to safe and effective medication delivery technology and long-term support of industry collaboration aligns closely with the NIC’s goal of fostering safer and more efficient medication management practices. We look forward to their participation.”

"B. Braun is proud to join the National Infusion Collaborative and work with other healthcare leaders to enhance infusion safety and patient care," said Jonathan Stapley, Senior Director of Marketing at B. Braun. "Our commitment to interoperability and patient-centered innovation aligns with the NIC's objectives, and we look forward to contributing to this important community."

Through the NIC, Bainbridge Health, B. Braun, and the other hospital, academic, and industry members aim to reduce medication errors, share best practices, and drive advancements in infusion therapy that improve healthcare delivery nationwide.

For additional information about Bainbridge Health and the National Infusion Collaborative, please visit bainbridgehealth.com/national-infusion-collaborative/.

About Purdue University

Purdue University is a public research university leading with excellence at scale. Ranked among top 10 public universities in the United States, Purdue discovers, disseminates and deploys knowledge with a quality and at a scale second to none. More than 107,000 students study at Purdue across multiple campuses, locations and modalities, including more than 58,000 at our main campus in West Lafayette and Indianapolis. Committed to affordability and accessibility, Purdue’s main campus has frozen tuition 13 years in a row. See how Purdue never stops in the persistent pursuit of the next giant leap — including its comprehensive urban expansion, the Mitch Daniels School of Business, Purdue Computes and the One Health initiative — at https://www.purdue.edu/president/strategic-initiatives.

About Bainbridge Health

A spin-off company of a Philadelphia-based Health System, Bainbridge Health is on a mission to solve Pharmacy's Biggest Challenges. Through its Med O.S.® platform of products, Bainbridge helps hospitals and health systems improve the safety, efficiency, and stewardship of medication delivery. We are proud to partner with hundreds of hospitals, health-systems and academic partners across the United States.

Media Contact: Joanne Hatfield, Pharm.D., BCPS Co-Chair, National Infusion Collaborative, [email protected]

About B. Braun

B. Braun Medical Inc. (B. Braun) is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. Our purpose is to help providers constantly improve patient satisfaction and outcomes. With products and services created to help healthcare professionals focus on what matters most—their patients—we’re uniquely positioned to help health systems succeed now and in the future. B. Braun is headquartered in Bethlehem, Pennsylvania and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®. The company employs 8,500 people at over 30 locations across North America.

Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, explore our website.

Joanne Hatfield
Bainbridge Health Inc
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.